3 Best Stocks to Buy Now, 8/6/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 8/6/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Axsome Therapeutics (AXSM) – This biopharmaceutical company develops therapies for central nervous system disorders such as depression and migraine. Today, Needham analyst Ami Fadia assigned a Buy rating on the stock with a $130 price target. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of about 38%.

Kemper (KMPR) – Kemper is a diversified insurance holding company. Today, JMP Securities analyst Matthew Carletti maintained a Buy rating on the stock and raised the price target to $85 from $80. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 24%.

BellRing Brands (BRBR) – BellRing Brands is engaged in the production of nutrition products, including protein shakes and bars. Today, Barclays analyst Andrew Lazar reiterated a Buy rating on the stock with a price target of $65. In the last three months, nine out of the 10 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 33%.

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
GlobeNewswireAxsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.
TheFlyAxsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz
TheFlyBiotech Alert: Searches spiking for these stocks today
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App